Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Signal Transduction

Parasympathetic Innervation and Function of Endocrine Pancreas Requires the Glial Cell Line–Derived Factor Family Receptor α2 (GFRα2)

  1. Jari Rossi1,
  2. Paavo Santamäki1,
  3. Matti S. Airaksinen1 and
  4. Karl-Heinz Herzig2
  1. 1Neuroscience Center, University of Helsinki, Helsinki, Finland
  2. 2Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, Department of Internal Medicine, University of Kuopio, Kuopio, Finland
  1. Address correspondence and reprint requests to Dr. Jari Rossi or Matti S. Airaksinen, Neuroscience Center, P.O. Box 56 (Viikinkaari 4), 00014 University of Helsinki, Finland. E-mail: jari.rossi{at}helsinki.fi or matti.airaksinen{at}helsinki.fi
Diabetes 2005 May; 54(5): 1324-1330. https://doi.org/10.2337/diabetes.54.5.1324
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Localization of the GFRα2 protein in Schwann cells and parasympathetic nerve fibers in the wild-type mouse endocrine pancreas. A–C: Colocalization (C, yellow) of GFRα2 (A, red) and S100β (B, green) in islets of Langerhans. The GFRα2 protein is localized in S100β+ Schwann cells encircling the islets. Some S100β- and GFRα2-containing glial processes are also present in the center of the islets (small arrow). Arrowheads indicate thin and varicose GFRα2+ and S100β− nerve fiber distributed randomly in the center of the islet. D–I: Most GFRα2+ (D and G, red) thin varicose nerve fibers (arrowheads) express the parasympathetic markers VAChT (E, green) and VIP (H, green). Colocalization is seen in yellow (F and I). The arrow points indicate GFRα2+ varicosities that are VIP−. J–K: The parasympathetic markers, VAChT (J, red) and VIP (K, green), show similar varicose staining and are colocalized (L, yellow) in most nerve fibers in the islets (arrowheads). Note that some of the varicosities contain either VIP or VAChT but not both of the markers (arrows). M–O: GFRα2 (M, red) (arrowheads) is not expressed in sympathetic nerve fibers (arrows) labeled with TH (N, green) in the islets. Bar equals 50 μm.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Reduced cholinergic innervation of islets of Langerhans in the GFRα2-KO mouse pancreas. A: VIP immunohistochemistry stains several varicose nerve fibers in wild-type islets. B: In the GFRα2-KO pancreas, many islet profiles are completely devoid of parasympathetic fibers (circled area in B), but some islets have apparently normal density of VIP+ innervation (arrow). D and E: Density of VAChT+ varicosities is reduced in GFRα2-KO islets. Bars equal 50 μm. C and F: Density histograms of islet parasympathetic innervation shown as percentage of islet profiles with a given density of immunopositive varicosities per islet area (arbitrary units). In the wild-type pancreas (▪), most islet profiles have moderate to high density of varicose, VIP+ (C), and VAChT+ (F) nerve fibers. In contrast, the number of islet profiles with low density of nerve fibers is greatly increased in the GFRα2-KO pancreas (□).

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Loss of vagally stimulated secretion of PP and insulin and diminished glucagon response in GFRα2-KO mice. A: In wild-type animals, 2-DG, a central vagal stimulant, induces secretion of PP. *P < 0.01 for WT vs. KO. After 30 min, plasma PP returned close to baseline levels in wild-type mice. In GFRα2-KO mice, 2-DG–induced PP secretion is absent. B: 2-DG induces secretion of insulin in wild-type but not GFRα2-KO mice. *P < 0.01 for WT baseline vs. 2-DG; †P < 0.001 for WT vs. KO. C: Secretion of glucagon is profoundly reduced in GFRα2-KO mice after 2-DG stimulation. *P < 0.001 for WT baseline vs. 2-DG; †P < 0.01 WT vs. KO; ‡P < 0.05 for KO baseline vs. 2-DG. D: Serum glucose levels before and after 2-DG. The glucose levels are measured from the same blood samples as in B. *P < 0.001 for WT baseline vs. 2-DG; †P < 0.001 for KO baseline vs. 2-DG. The number of animals in each group is presented in parentheses.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Normal systemic glucose tolerance and insulin response in GFRα2-KO mice. Plasma glucose (A) and insulin (B) values are similar for wild-type and GFRα2-KO mice before and after an intraperitoneally administered glucose load (2 mg/g body wt).

PreviousNext
Back to top

In this Issue

May 2005, 54(5)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Parasympathetic Innervation and Function of Endocrine Pancreas Requires the Glial Cell Line–Derived Factor Family Receptor α2 (GFRα2)
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Parasympathetic Innervation and Function of Endocrine Pancreas Requires the Glial Cell Line–Derived Factor Family Receptor α2 (GFRα2)
Jari Rossi, Paavo Santamäki, Matti S. Airaksinen, Karl-Heinz Herzig
Diabetes May 2005, 54 (5) 1324-1330; DOI: 10.2337/diabetes.54.5.1324

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Parasympathetic Innervation and Function of Endocrine Pancreas Requires the Glial Cell Line–Derived Factor Family Receptor α2 (GFRα2)
Jari Rossi, Paavo Santamäki, Matti S. Airaksinen, Karl-Heinz Herzig
Diabetes May 2005, 54 (5) 1324-1330; DOI: 10.2337/diabetes.54.5.1324
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Activation of dsRNA-Dependent Protein Kinase R by miR-378 Sustains Metabolic Inflammation in Hepatic Insulin Resistance
  • STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity
  • Maternal Obesity and Western-Style Diet Impair Fetal and Juvenile Offspring Skeletal Muscle Insulin-Stimulated Glucose Transport in Nonhuman Primates
Show more Signal Transduction

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.